Table 1

Baseline characteristics of participants* in intervention and control arms

	Baseline 1 (before follow-up began)				Baseline 2 (before training began)
	Control		Intervention		Control		Intervention
	N	%	N	%	N	%	N	%
Participants with asthma	2206	100.0	2017	100.0	2161	100.0	1918	100.0
Sex (male)	614	27.8	515	25.5	591	27.4	485	25.3
Inhaled corticosteroid ever	820	37.2	814	40.4	752	34.8	703	36.7
Short acting beta₂-agonist ever	761	34.5	755	37.4	705	32.6	652	34.0
Long acting beta₂-agonist+ICS ever	302	13.7	320	15.9	269	12.5	275	14.3
Any of the above ever prescribed	995	45.1	1005	49.8	911	42.2	883	46.0
†Asthma score=0	1782	80.8	1502	74.5	1748	80.9	1483	77.3
Asthma score=1	366	16.6	428	21.2	348	16.1	369	19.2
Asthma score=2	58	2.6	87	4.3	65	3.0	66	3.4
Asthma score: start or change treatment‡	339	15.4	387	19.2	319	14.8	333	17.4
Asthma score: spirometry‡	143	6.5	215	10.7	159	7.4	168	8.8
COPD ever diagnosed	442	20.0	468	20.2	437	20.2	453	23.6
	Mean	SD	Mean	SD	Mean	SD	Mean	SD
Clinic level asthma score	0.214	0.107	0.293	0.124	0.206	0.110	0.287	0.119
Age (years)	48.3	18.0	49.1	17.9	48.0	18.8	48.7	17.8
	N	%	N	%	N	%	N	%
Participants with COPD	1042	100.0	1190	100.0	1025	100.0	1169	100.0
Sex (male)	450	43.2	493	40.7	445	43.4	471	40.3
Inhaled corticosteroid ever	343	32.9	390	32.2	306	29.9	342	29.5
Short acting beta₂-agonist ever	302	29.0	341	32.2	274	26.7	299	25.6
Long acting beta₂-agonist+ICS ever	213	20.9	264	28.1	188	18.3	223	19.1
Any of the above ever prescribed	463	44.4	549	45.3	417	40.7	482	41.2
COPD score=0†	88.1	84.6	943	77.8	849	82.8	948	81.1
COPD score=1	130	12.5	220	18.2	145	14.2	175	15.0
COPD score=2	31	3.0	48	4.0	31	3.0	46	4.9
COPD score: start or change treatment‡	93	8.9	137	11.3	95	9.3	125	10.7
COPD score: spirometry‡	99	9.5	181	14.9	112	10.9	142	12.2
Asthma ever diagnosed	442	42.4	468	38.6	437	42.6	453	38.8
	Mean	SD	Mean	SD	Mean	SD	Mean	SD
Age (mean)	62.2	13.4	61.9	13.4	61.7	13.1	61.1	13.6
	N	%	N	%	N	%	N	%
Participants with asthma or COPD	2806	100.0	2761	100.0	2749	100.0	2632	100.0
Sex (male)	885	31.5	840	30.4	857	31.2	794	30.1
Cardiovascular disease newly diagnosed§	91	3.2	124	4.5	1147	4.2	130	4.9
Cardiovascular risk assessed¶	1785	63.6	1751	63.4	1829	66.5	1791	68.0
Diabetes newly diagnosed	91	3.2	113	4.1	86	3.1	97	3.7
Nicotine or buproprion or nortriptyline prescribed	76	2.7	102	3.7	87	3.2	90	3.4
Depression newly diagnosed	69	2.5	107	3.9	65	2.4	80	3.0
Antidepressant treatment started	87	3.1	118	4.3	105	3.8	117	4.4
	Mean	SD	Mean	SD	Mean	SD	Mean	SD
Clinic level COPD score	0.186	0.078	0.269	0.173	0.202	0.834	0.225	0.102
Age (years)	51.3	18.0	52.7	17.8	51.1	17.8	52.2	17.6
Clinic level diagnosis and hospital admission ratios**
New asthma and COPD diagnoses	10.3	4.2	10.9	4.7	11.2	4.3	9.5	3.1
New asthma diagnoses	7.3	3.2	7.4	3.9	7.8	3.7	6.2	2.7
New COPD diagnoses	3.0	1.9	3.6	2.2	3.4	1.4	3.3	1.4
Hospital admissions for asthma or COPD	1.3	1.1	0.80	0.61	0.57	0.65	0.59	0.46

*Excludes participants newly diagnosed with asthma or COPD during follow-up.
†Primary outcomes.
‡Components added to create primary outcomes.
§ICD-10 I00–I99.
¶Blood pressure, cholesterol,glucose and/or ECG recorded.
**No of new diagnoses or hospital admissions: 1000 adults visiting clinic during the year.
COPD, chronic obstructive pulmonary disease; ICS, inhaled corticosteroid.